









© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of 
America. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, 
distribution, and reproduction in any medium, provided the original work is properly cited. 




Ekta Lachmandas1, Ana B Rios-Miguel1, Valerie A C M Koeken1, Eva van der Pasch1, Vinod Kumar1,2, 
Vicky Matzaraki2, Yang Li2, Marije Oosting1, Leo A B Joosten1, Richard A Notebaart1,4, Mahdad 
Noursadeghi3, Mihai G Netea1, Reinout van Crevel1 and Gabriele Pollara3* 
1Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University 
Medical Center, PO Box 9102, Nijmegen, The Netherlands 
2University of Groningen, UMC Groningen, P.O. Box 30001, Groningen, Netherlands 
3Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom 
4Laboratory of Food Microbiology, Wageningen University and Research, Wageningen, the 
Netherlands 
 




Conflict of interests 
The authors do not have a commercial or other association that might pose a conflict of interest 
relating to the content of the manuscript. 
 
Funding 
This work was supported by the Wellcome Trust Research Fellowship to GP (WT101766/Z/13/Z), 
Wellcome Trust Investigator Award to MN (207511/Z/17/Z), the National Institute for Health 
Research Biomedical Research Centre at University College London Hospital, and by an ERC 
Consolidator Grant to MGN (#310372) and a Spinoza grant of the Netherlands Organization for 
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiy173/4959339
by Institute of Child Health/University College London user












Scientific Research (to MGN). RvC and EL were supported by The European Union’s Seventh 
Framework Programme (EU FP7) project TANDEM (HEALTH-F3-2012-305279). 
 
Presentations 
The information in this manuscript has not been presented at any meetings.  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiy173/4959339
by Institute of Child Health/University College London user













Cellular metabolism can influence host immune responses to Mycobacterium tuberculosis (Mtb). 
Using a systems biology approach, differential expression of 292 metabolic genes involved in 
glycolysis, glutathione, pyrimidine and inositol phosphate pathways was evident at the site of a 
human tuberculin skin test challenge in patients with active tuberculosis infection. For 28 metabolic 
genes, we identified single nucleotide polymorphisms (SNPs) that were trans-acting for in vitro 
cytokine responses to Mtb stimulation, including glutathione and pyrimidine metabolism genes that 
alter production of Th1 and Th17 cytokines. Our findings identify novel therapeutic targets in host 
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The activity of many cellular metabolic pathways can impact the host immune response to infections 
[1]. Individual metabolic pathways have been implicated in anti-mycobacterial responses: 
glutathione enhances IL-12 and IFN secretion following Mtb stimulation [2]; tryptophan catabolism 
is involved in Mtb-induced production of IL-1 and IL-23 [3] and control of Mtb growth [4]; and a 
shift towards aerobic glycolysis in Mtb infected macrophages regulates IL-1 production [5,6]. 
However, as metabolic reactions are intrinsically inter-dependent, the challenge lies in determining 
the relative roles of these and other pathways during in vivo Mtb infection. 
Our group has made use of the human tuberculin skin test (TST) challenge model to faithfully reflect 
the inflammatory changes that occur at the site of tuberculosis (TB) disease, characterising the tissue 
immunological pathways induced early after mycobacterial antigen exposure [7]. However, to date, 
no studies have explored the metabolic changes and their functional consequences on downstream 
cytokine responses in such a model. Quantitative cytokine production in response to mycobacterial 
stimulation has been associated with genetic polymorphisms [8]. These cytokine quantitative trait 
loci (cQTLs) provide a functional insight into how genetics influences an inflammatory response, and 
in turn identify critical pathways that may be amenable to host-directed therapy. In this study, we 
use the TST model to test the hypothesis that differential tissue expression of genes involved in 
regulating metabolic pathways can directly influence cytokine production following Mtb stimulation. 
In turn, our findings provide putative mechanistic links between the activity of cellular metabolic 
pathways and immune effector functions.  
  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiy173/4959339
by Institute of Child Health/University College London user













Transcriptomic data analysis 
Transcriptomes were derived from TST and blood of patients with active TB, and human Mtb-
infected and healthy lymph nodes from a separate cohort (table S1). All patients were HIV 
seronegative and none had diabetes mellitus.    
We used the KEGG pathway database (http://www.genome.jp/kegg/pathway.html) to derive 33 
pathways associated with human metabolism, yielding a list of 1422 metabolic genes containing no 
duplicate genes and no annotation to the original pathways (Tables S2 & S3). Bioinformatic analyses 
were performed as previously described [7] (see Supplementary Methods). 
 
SNP extraction and cQTL mapping 
Single nucleotide polymorphisms (SNPs) within metabolic genes and cQTLs were identified as 
previously described [8] (see Supplementary Methods).  
 
Metabolite reporter analysis  
Reporter metabolite analysis [9] was performed in Matlab using the RAVEN Toolbox (http://biomet-
toolbox.org/index.php?page=downtools-raven) and the human genome-scale metabolic 
reconstruction network HMR 2.00 provided in Human Protein Atlas 
(http://www.metabolicatlas.org/downloads/hmr) (see Supplementary Methods). 
 
Metabolite depletion experiments 
Peripheral blood mononuclear cells (PBMC) were isolated from 9 healthy Dutch adult volunteers and 
stimulated with Mtb lysate in the presence or absence of pharmacological manipulators of the 
glutathione pathway (see Supplementary Methods).  
Results 
We have previously demonstrated that the transcriptional response at the site of TST is 
characterised by upregulation of 1725 genes that closely reflect changes seen in dissected human TB 
granuloma relative to healthy lung tissue [7]. We now show that the TST signature is also enriched 
within Mtb-infected relative to healthy lymph nodes (Figure 1A), confirming that the TST 
transcriptional responses mirrors pathology seen at established sites of human TB disease.  
Out of 1422 metabolic genes, 292 were differentially expressed at the site of TST versus saline 
injection in patients with active TB disease (Figure S1 and Table S4). Expression of these genes at 
tissue level showed a remarkable lack of concordance with the blood transcriptome of the same 
patients, as only 9 metabolic genes were differentially expressed in the blood (Figure 1B, Figure S2 & 
Table S5). This demonstrates that the TST challenge model provides greater molecular resolution to 
identify host differential metabolic gene expression to mycobacterial infection than the blood 
compartment [7]. 
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Given the interconnected relationship between multiple metabolic pathways, we generated a 
network depicting the ten most enriched KEGG annotated metabolic pathways based on the 292 
differentially expressed metabolic genes (Figure 1C). As expected, the TST induced changes in 
multiple inter-linked metabolic pathways. These included not only previously described pathways 
such as glycolysis and glutathione metabolism, but also others such as inositol phosphate 
metabolism and specific amino acid metabolic pathways not previously associated with TB [1,2]. 
Since differentially expressed genes within the same metabolic pathway were both up- or down-
regulated (Figure S3), we evaluated which metabolites in these pathways were most affected using 
Reporter Metabolite analysis. This identified metabolites in the human metabolic network around 
which the most transcriptional changes occur [10]. The model predicted changes in several key 
metabolites between TST and saline, including 1,3-bisphospho-D-glycerate (glycolysis), L-
formylkynurenine (tryptophan metabolism), 1-phosphatidyl-1D-myo-inositol-3,4-bisphosphate and 
glutathione (Figure 1D). Therefore, the model predicts that gene expression changes n the TST alter 
the concentration of several bioactive metabolites in multiple pathways, and that this has the 
potential to impact the nature of the host immune response to Mtb.  
Next, we sought to test the hypothesis that metabolic changes in the tissue environment influence 
Mtb-induced cytokine production. We used natural genetic variation to identify putative cis-acting 
SNPs for metabolic gene expression and tested whether they might be trans-acting SNPs for cytokine 
responses. We identified metabolic genes differentially expressed in the TST and assessed their 
impact on cytokine secretion following Mtb lysate-stimulation in a cohort of 500 healthy individuals 
[8]. First, we used genotypes extracted from the 1000 Genomes Project to identify 16061 SNPs from 
the 109 metabolic genes that comprised the 10 most enriched metabolic pathways in the TST (Figure 
1C). We then assessed which of these SNPs were associated with variable cytokine secretion, 
generating 2376 putative cQTLs. To reduce multiple testing false positives, we focused on SNPs in 
the mRNA coding region of the gene of interest that influence the same gene’s transcription (i.e. 
metabolic gene SNPs that were cis-expression QTLs [eQTLs]). 
This analysis generated 47 cQTL SNPs from 28 metabolic genes (Figures 2A-B & Tables S6 & S7). 
Based on these genes, the most over-represented metabolic pathways included the glutathione, 
glycolysis, inositol phosphate metabolism and pyrimidine pathways (Figure S4). Many amino acid 
metabolism pathways were also observed, and ALDH3A2, ALDH3A1, LDHA and IL4I1 were the most 
frequent constituent genes from these pathways (Figure S4). Glutathione and pyrimidine 
metabolism predominantly influenced the secretion of IFN and IL-17: 7 of 15 (47%) cQTLs that 
regulated IFN secretion and 4 of 7 (57%) cQTLs that regulated IL-17 secretion were derived from 
genes assigned to glutathione or pyrimidine metabolic pathways, whereas no cQTLs from these 
pathways influenced cytokine secretion by macrophages (Figure 2B). In contrast, genes involved in 
glycolysis, amino acid and inositol phosphate metabolism acted as cQTLs more ubiquitously, 
influencing the secretion of both T cell and myeloid cell derived cytokines (IL-1, IL-6, IL-22 and 
TNF) (Figure 2B).  
We validated some of the relationships between metabolic changes and cytokine secretion in vitro 
using buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis, and diethylmaleate (DEM) 
that depletes cells of glutathione [11]. Both resulted in increased IL-6 and decreased IL-17 secretion 
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by Mtb stimulated PBMC (fig 2C), consistent with the cQTL data demonstrating that variable 
expression of glutathione genes impacted the secretion of both these cytokines (fig 2B).  
Finally, to explore the physiological relevance of the 28 metabolic genes that act as cQTLs, we 
showed that their expression in Mtb-infected lymph nodes strongly correlated with expression  in 
the TST (Figure 2D), indicating that these metabolic genes have the potential to exert cQTL activity at 
the site of human TB disease, thus shaping the local inflammatory response to Mtb. 
  
Downloaded from https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiy173/4959339
by Institute of Child Health/University College London user













Individual metabolic pathways have been shown to affect the host response to Mtb [2,3,5], but their 
relative contribution in a multicellular tissue infection setting has not been investigated. We took a 
systems approach using the human in vivo TST challenge model, revealing gene expression changes 
in multiple metabolic pathways that in turn predict enrichment of several bioactive metabolites. 
Genetic polymorphisms in these differentially expressed metabolic genes, as well as pharmacological 
inhibition, were found to control Mtb-induced cytokine production. Finally, expression of these same 
genes at the site of TB disease closely correlated that observed in the TST, underlying the functional 
relevance of our findings to the pathogenesis of human TB infection. 
The inflammatory response to TST challenge reflects the immunopathological changes in human TB 
disease [7]. Interestingly, in terms of metabolic gene expression the TST site also closely mirrors 
Mtb-infected lymph nodes, unlike the peripheral blood of TB patients, which showed quantitatively 
smaller changes. Although this may reflect the TST response occurring after acute antigenic 
challenge in contrast to steady state assessment in blood,  in these same patients the blood 
transcriptome shows significant deviation from health [7,12], illustrating that tissue may be the 
more appropriate context when studying changes in metabolism.  
We observed differential gene expression in the TST of multiple metabolic pathways, including 
glycolysis, glutathione, pyrimidine and inositol phosphate metabolism. The relevance of changes in 
the metabolic environment after Mtb infection was supported by the fact that we identified several 
SNPs in these genes that both act as cis-eQTLs and also impact Mtb-induced cytokine secretion by 
PBMC and macrophages [8], cells that are enriched at the site of TST [7]. For functional validation, 
we selected one of the pathways identified through gene expression and cQTL-analysis, the 
glutathione pathway, whereby pharmacological inhibition affected Mtb-induced production of IL-6 
and IL-17. Importantly, the 500FG cohort data demonstrated that variable expression of genes 
involved in glutathione metabolism (GSTM2, ANPEP, LAP3 and GSTA3) impacted the secretion of 
these same cytokines. Furthermore, we have previously demonstrated that inhibiting glycolysis using 
2-deoxyglucose impaired IL-22 secretion by Mtb-stimulated PBMC, in turn validating the observation 
from the 500FG data that SNPs in the glycolysis gene ADPGK are cQTLs for IL-22 secretion [6].   
Our analyses also identified new roles for pyrimidine metabolism, which has recently been 
associated with regulating inflammasome activity and cytokine secretion [13]. We demonstrate that 
pyrimidine and glutathione metabolism genes predominantly impact the secretion of T cell-derived 
cytokines IFN and IL-17. As such, therapeutic manipulation of pyrimidine and glutathione pathways 
may influence Th1 and Th17 polarisation, and thus the balance between protection and pathology in 
Mtb-infected tissues [14]. In contrast, genes involved in amino acid and inositol phosphate 
metabolism impact a wider array of cytokines, including those secreted from myeloid cells, which 
may in part relate to the central role of the metabolite phosphatidylinositol as the backbone of 
signal transduction components IP3 and Akt [6]. 
Our study has some limitations. Firstly, we restricted our cQTL analyses to SNPs that were also cis-
eQTLs to limit multiple testing errors, thus likely missing other functionally relevant cQTLs that may 
act in trans via other genes. Equally, identification of SNPs that were eQTLs was limited to databases 
that probed blood and tissues not infected with Mtb, possibly missing other functionally relevant 
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SNPs in the context of Mtb infection. Furthermore, the effector cytokines studied for cQTL analysis 
comprise only one facet of the host immune response to Mtb infection and were restricted to the 
manually selected panel available in the 500FG database, introducing bias into the breadth of 
immunological effector functions exerted by metabolic gene SNPs. Finally, although Reporter 
Metabolite analysis predicted computationally that the gene expression changes impacted on the 
concentration of several key metabolites, we were not able to assess this directly. The study was 
conceived retrospectively, and thus tissue samples had already been used wholly for transcriptomic 
analysis. The relationship between tissue gene expression changes and metabolite concentrations 
will need to be verified experimentally in future studies. 
In summary, this study made a comprehensive assessment of the human tissue metabolic 
transcriptional response to in vivo mycobacterial antigenic stimulation. A number of known and 
novel metabolic pathways were differentially expressed, and genetic variation in identified genes 
affected cytokine responses to Mtb. Therefore, our systems approach provided a novel list of 
putative metabolic gene cQTLs that are amenable to further experimental validation, and revealed a 
new layer of complexity to the host anti-mycobacterial response, supporting the use of host-directed 
strategies that target cellular metabolism, such as the regulation of glycolysis by metformin [15]. 
Furthermore, our approach combining transcriptomics and functional genomics illustrates a pipeline 
that can be used to identify novel and clinically relevant pathways in the context of other infectious 
diseases.   
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Figure 1: Metabolic pathways enriched in TST responses relative to saline injection. 
(A) Expression of TST signature in Mtb infected lymph nodes (LN) relative to healthy LN. Each dot 
represents one sample.  Horizontal lines represent median value expression. * p<0.0001 by Mann-
Whitney test. (B) Pairwise comparison of 292 genes differentially expressed in TST relative to saline 
injection compared to the expression difference between the blood of patients with active TB and 
healthy volunteers (HV). r2 = Spearman’s rank correlation coefficient, CoV = covariance. (C) The top 
ten most statistically enriched KEGG metabolic pathways are represented in a network plot, in which 
the edges indicate associations between genes (yellow nodes) and named pathways (blue nodes), 
and the node size is proportional to the respective pathway -log10 p value enrichment statis ic. (D) 
Reporter metabolites predicted to be differentially expressed in TST compared to saline injection. 
Metabolites selected for known association with metabolic pathways and ranked by increasing p 
value. 
 
Figure 2: Identification of cQTLs within metabolic genes differentially expressed in a TST. 
(A) Representative box plots of association between SNP genotypes and Mtb-induced cytokine 
levels. Length of the box is the interquartile range and whiskers indicate the range of 1.5 × the length 
of the box from either end of the box. P values were obtained using linear regression analysis of 
cytokine on genotype data. (B) Heatmap of all 47 cQTL SNPs and their relationship to cytokine 
secretion following PBMC or macrophage (Mfs) stimulation with Mtb lysate. (C) IL-6 & IL-17 
secretion from Mtb lysate-stimulated PBMC in the presence or absence of BSO or DEM. Horizontal 
lines represent median value expression. * p<0.01 Wilcoxon signed-rank test. (D) Gene expression of 
28 metabolic genes with cQTL SNPs in TST relative to saline compared to the expression in Mtb 
infected lymph nodes relative to healthy lymph nodes. r2 = Spearman’s rank correlation coefficient. 
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